EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Predictors and surgical outcome of hemorrhagic metastatic brain malignancies

Laurèl Rauschenbach, Pia Kolbe, Adrian Engel, Yahya Ahmadipour, Marvin Darkwah Oppong, Alejandro N Santos, Sied Kebir, Celia Dobersalske, Björn Scheffler, Cornelius Deuschl, Philipp Dammann, Karsten H Wrede und 2 weitere

Journal of Neuro-Oncology · 2024-08 · 169 (1) · 165-173

DOI: 10.1007/s11060-024-04714-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neuro-Oncology, online erschienen am 27.05.2024. Verfasst von Laurèl Rauschenbach und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery and Spine Surgery, University Hospital Essen, Hufelandstrasse 55, 45147, Essen, Germany. laurel.rauschenbach@uk-essen.de. Hauptthemen laut MEDLINE: Brain Neoplasms, Cerebral Hemorrhage. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Essen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Intracerebral metastases present a substantial risk of tumor-associated intracerebral hemorrhage (ICH). This study aimed to investigate the risk of hemorrhagic events in brain metastases (BM) from various primary tumor sites and evaluate the safety and outcomes of surgical tumor removal.

Methods

A retrospective, single-center review of medical records was conducted for patients who underwent BM removal between January 2016 and December 2017. Patients with hemorrhagic BM were compared to those with non-hemorrhagic BM. Data on preoperative predictors, perioperative management, and postoperative outcomes were collected and analyzed.

Results

A total of 229 patients met the inclusion criteria. Melanoma metastases were significantly associated with preoperative hemorrhage, even after adjusting for confounding factors ( p = 0.001). Poor clinical status ( p = 0.001), larger tumor volume ( p = 0.020), and unfavorable prognosis ( p = 0.001) independently predicted spontaneous hemorrhage. Importantly, preoperative use of anticoagulant medications was not linked to increased hemorrhagic risk ( p = 0.592). Surgical removal of hemorrhagic BM, following cessation of blood-thinning medication, did not significantly affect intraoperative blood loss, surgical duration, or postoperative rebleeding risk ( p > 0.096). However, intra-tumoral hemorrhage was associated with reduced overall survival ( p = 0.001).

Conclusion

This study emphasizes the safety of anticoagulation in patients with BM and highlights the safety of neurosurgical treatment in patients with hemorrhagic BM when blood-thinning medication is temporarily paused. The presence of intra-tumoral hemorrhage negatively impacts survival, highlighting its prognostic significance in BM patients. Further research with larger cohorts is warranted to validate these findings and elucidate underlying mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsCerebral HemorrhageHumansMaleFemaleMiddle AgedRetrospective StudiesAgedPrognosisTreatment OutcomeAdultNeurosurgical ProceduresRisk Factors

Stichwörter der Autor:innen

Brain metastasisHemorrhagic brain tumorIntracerebral hemorrhageOutcome

Autor:innen und Institutionen

  • Department of Neurosurgery and Spine Surgery, University Hospital Essen, Hufelandstrasse 55, 45147, Essen, Germany. laurel.rauschenbach@uk-essen.de.
  • DKFZ Division of Translational Neurooncology at the West German Cancer Center (WTZ), University Hospital Essen, Essen, Germany. laurel.rauschenbach@uk-essen.de.
  • Center for Translational Neuroscience and Behavioral Science (C-TNBS), University of Duisburg-Essen, Essen, Germany. laurel.rauschenbach@uk-essen.de.
  • Department of Neurosurgery and Spine Surgery, University Hospital Essen, Hufelandstrasse 55, 45147, Essen, Germany.
  • Center for Translational Neuroscience and Behavioral Science (C-TNBS), University of Duisburg-Essen, Essen, Germany.
  • DKFZ Division of Translational Neurooncology at the West German Cancer Center (WTZ), University Hospital Essen, Essen, Germany.

Förderung

  • Universitätsklinikum Essen

Zitieren

APA

Rauschenbach, L., Kolbe, P., Engel, A., Ahmadipour, Y., Oppong, M. D., Santos, A. N., Kebir, S., Dobersalske, C., Scheffler, B., Deuschl, C., Dammann, P., Wrede, K. H., Sure, U., & Jabbarli, R. (2024). Predictors and surgical outcome of hemorrhagic metastatic brain malignancies. Journal of Neuro-Oncology, 169(1), 165-173. https://doi.org/10.1007/s11060-024-04714-2

Vancouver

Rauschenbach L, Kolbe P, Engel A, Ahmadipour Y, Oppong MD, Santos AN, et al. Predictors and surgical outcome of hemorrhagic metastatic brain malignancies. Journal of Neuro-Oncology. 2024;169(1):165-173. doi:10.1007/s11060-024-04714-2

BibTeX
@article{Rauschenbach2024,
  author = {Rauschenbach, Laurèl and Kolbe, Pia and Engel, Adrian and Ahmadipour, Yahya and Oppong, Marvin Darkwah and Santos, Alejandro N and Kebir, Sied and Dobersalske, Celia and Scheffler, Björn and Deuschl, Cornelius and Dammann, Philipp and Wrede, Karsten H and Sure, Ulrich and Jabbarli, Ramazan},
  title = {Predictors and surgical outcome of hemorrhagic metastatic brain malignancies},
  journal = {Journal of Neuro-Oncology},
  year = {2024},
  volume = {169},
  number = {1},
  pages = {165--173},
  doi = {10.1007/s11060-024-04714-2}
}
Kostenlos starten →